[191954] in SIPB-AFS-requests
Our #1 Takeover Target for September
daemon@ATHENA.MIT.EDU (Haley Rufino)
Sat Apr 25 21:47:59 2020
From haley.rufino-sipb+2Dafsreq+2Dmtg=charon.mit.edu@churchofideal.online Sun Apr 26 01:47:59 2020
Return-Path: <haley.rufino-sipb+2Dafsreq+2Dmtg=charon.mit.edu@churchofideal.online>
Delivered-To: sipb-afsreq-mtg@charon.mit.edu
Received: (qmail 19598 invoked from network); 26 Apr 2020 01:47:35 -0000
Received: from churchofideal.online (HELO mail.churchofideal.online) (213.142.156.129)
by charon.mit.edu with SMTP; 26 Apr 2020 01:47:35 -0000
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=dkim; d=churchofideal.online;
h=Date:From:To:Subject:MIME-Version:Content-Type:List-Unsubscribe:Message-ID; i=haley.rufino@churchofideal.online;
bh=/jhm91uH+quJKVZXNrc6cHe3wpk=;
b=qFRgyS1o2Vz2LQ5S2GUuTAauJti9Tr+3hPU/slVkkO8cYXV1mKmh0r0Ek7TSMD3yNIU/enfqauN9
vPhzI2UMI2I0rdpb5a4jyTBdiMqSEuRVUGebm61lrrR8M9qckTm2YVhITFlsureeUZvT4nNL1XuT
nB8fc6eqrM7th3FAk90=
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=dkim; d=churchofideal.online;
b=F7kQo5YZYK+Qom5p20L/9HaSAqvxvjTXFQZSo0nsPkVa2Yz+6vh5doIPnfYbzTHlspqNsAr4X8ts
kTkM4dI3dZ6XHIopZ9giycHPbEFxPlU8H6rtVRyCWOg8T4Z5AaPHbDzU9z9f9BxUGwK9MHcxwssq
tsMQBeZQum0omvL2pEw=;
Received: by mail.churchofideal.online id hkjk3m0001g6 for <sipb-afsreq-mtg@charon.mit.edu>; Sat, 25 Apr 2020 20:50:30 -0400 (envelope-from <haley.rufino-sipb+2Dafsreq+2Dmtg=charon.mit.edu@churchofideal.online>)
Date: Sat, 25 Apr 2020 20:50:30 -0400
From: Haley Rufino <haley.rufino@churchofideal.online>
To: <sipb-afsreq-mtg@charon.mit.edu>
Subject: Our #1 Takeover Target for September
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_Part_340_1036999526.1587862212541"
List-Unsubscribe: <http://www.churchofideal.online/98f4Y2395u8I9K11O1mn1gPad4y31XwbtF-DYwvIu-ixZfGaDvsrEibxEIH47fQ4oKn97wNo10PV10DyiwJLkBx9/pints-Germantown>
Message-ID: <0.0.0.25.1D61B64AF1CAD20.63F720@mail.churchofideal.online>
------=_Part_340_1036999526.1587862212541
Content-Type: text/html; charset=us-ascii
Content-Transfer-Encoding: 7bit
<html>
<head>
<title>Our #1 Takeover Target for September</title>
</head>
<body>
<div class="email-background" style="font-family:Helvetica;font-size:18px;line-height:23px;padding-top:40px;padding-bottom:40px;padding-right:20px;padding-left:20px;">
<div>
Dear Fellow Skeptic,
</div>
<div>
On November 16, 2016,
<b>CBS News</b> shocked the medical world when they reported on a tiny biotech that
<b>restored blindness in mice</b>. </div>
<div>
The breakthrough was the first to reveal a revolutionary new treatment that could simply replace sick genes with healthy ones. </div>
<div>
Scientists called it
<i><b>"the most consequential discovery in medicine."</b></i>
</div>
<div>
They said it was
<i><b>"giving them power they could only imagine before."</b></i>
</div>
<div>
That's because this new breakthrough can
<u>treat all 6,000 genetic diseases</u>. </div>
<div>
But scientists aren't the only ones who see its true potential -
</div>
<div>
As the true power of this treatment comes into focus, it's become a
<b>national security issue</b> for us and our NATO allies. And that's what makes this breakthrough so unique:
</div>
<div>
It's not just about money anymore -
<u>it's about which country is going to lead in the future of medicine for <b>the next 50 years</b></u>. </div>
<div>
That's the real reason
<b>President Trump</b> signed
<u>"Executive Order 13771"</u> just 10 days after taking office... </div>
<div>
...for us to win the battle for the future,
<b>Trump had to reduce regulations at the FDA first</b>. </div>
<div>
This treatment will not just change medicine -
<b>it has the potential to eliminate genetic disease for our species</b>. </div>
<div>
And because of that,
<u>it's going to create more millionaires than any other single breakthrough in history</u>. More than 5G, more than cannabis and more than the internet. </div>
<div>
There's a
<b>tiny biotech that won the patent on this breakthrough</b>. </div>
<div>
The current market capitalization is just $1.5 billion. </div>
<div>
But analysts like Keith Speights experts expect it to soar to
<b>what Facebook is worth</b>, or $1 Trillion, by 2021. </div>
<div>
That's because Wall Street sees the potential of Amgen. </div>
<div>
Early investors in Amgen, one of the pioneers of biological medicine,
<b><i>earned as much as 46,751% on their money.</i></b>
</div>
<div>
<b><a href="http://www.churchofideal.online/supporting-ohmmeter/2c46a2X39y5lUI8612X43b5TSNad4r31KwbtF-DYwvIu-ixZfGaDvsrEibxEIH47RQ4oKn96N10RwX10mkLqi1w2x9" style="color:#1264BE;">Our research proves that anyone who gets in today could turn every $1,000 into $1.57 million (or more)! </a> </b>
</div>
<div>
That's if the company doesn't get taken over for fast 300% gains first. </div>
<div>
<b><a href="http://www.churchofideal.online/supporting-ohmmeter/2c46a2X39y5lUI8612X43b5TSNad4r31KwbtF-DYwvIu-ixZfGaDvsrEibxEIH47RQ4oKn96N10RwX10mkLqi1w2x9" style="color:#1264BE;">CLICK HERE to see how you can profit from this rare opportunity>>> </a> </b>
</div>
<br />
<br />
<div>
"The Buck Stops Here"
</div>
<p>Dylan<br /> Chairman<br /> <i>Behind the Markets</i><br /> <br /> <br /> <br /> </p>
</div>
<p align="left"><font size="2">To stop receiving messages, please visit <a href="http://www.churchofideal.online/supporting-ohmmeter/a266U239oK5M86k_10v43b6jad4k31iwbtF-DYwvIu-ixZfGaDvsrEibxEIH47LQ4oKn97dqAT1n09SpO3ilwx9">here</a>.<br /> Or mail your request to:<br /> Behind the Markets, LLC<br /> P.O. Box 2715 Boca Raton., 33427</font></p>
<div>
<span style="font-family:times new roman,times,serif;"><span style="font-size:10px;">To be removed <a href="http://www.churchofideal.online/helpmate-bludgeons/e406n2K39g5wYi8910k43b7Oad4w31zwbtF-DYwvIu-ixZfGaDvsrEibxEIH47pQ4oKn97i1jQPO09V3JXjiwx9">view here</a><br /> 11407 SW Amu St. Attn: 4260 Tualatin, OR 97062</span></span>
</div>
<img src="http://www.churchofideal.online/2fM6d23M9Y5HB8F512E43bJ8QMad4_31ewbtF-DYwvIu-ixZfGaDvsrEibxEIH47IQ4oKn97NwwAC109o3PjNiwx9/aborigine-thermodynamics" alt=""/></body>
</html>
------=_Part_340_1036999526.1587862212541--
